Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008418
Filing Date
2017-11-07
Accepted
2017-11-07 17:15:37
Documents
68
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tsro-20170930x10q.htm 10-Q 2015814
2 EX-10.1 tsro-20170930ex1012e9301.htm EX-10.1 711965
3 EX-31.1 tsro-20170930ex311daf7c1.htm EX-31.1 18942
4 EX-31.2 tsro-20170930ex312a97258.htm EX-31.2 18940
5 EX-32.1 tsro-20170930ex3211120a5.htm EX-32.1 7265
6 EX-32.2 tsro-20170930ex322712dc9.htm EX-32.2 7455
  Complete submission text file 0001558370-17-008418.txt   8583384

Data Files

Seq Description Document Type Size
7 EX-101.INS tsro-20170930.xml EX-101.INS 1809001
8 EX-101.SCH tsro-20170930.xsd EX-101.SCH 49577
9 EX-101.CAL tsro-20170930_cal.xml EX-101.CAL 47855
10 EX-101.DEF tsro-20170930_def.xml EX-101.DEF 215842
11 EX-101.LAB tsro-20170930_lab.xml EX-101.LAB 459640
12 EX-101.PRE tsro-20170930_pre.xml EX-101.PRE 371035
Mailing Address 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451 (339) 970-0900
TESARO, Inc. (Filer) CIK: 0001491576 (see all company filings)

EIN.: 272249687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35587 | Film No.: 171184376
SIC: 2834 Pharmaceutical Preparations